Figure 4
Figure 4. Enhanced clearance of MHCI-deficient target cells by ItpkB−/− NK cells. (A) MHCI+/+ or MHCI−/− splenocytes were labeled with low or high CFSE amounts, respectively. A 1:1 mixture was injected IV into WT versus ItpkB−/− mice. CFSElow versus CFSEhigh target cell content in recipient spleens was assessed 24 hours later. (B) Statistical analysis of the ratio (± SEM) of WT control to MHCI−/− targets harvested from recipient spleens (n = 5) revealed significantly underrepresented MHCI−/− targets in ItpkB−/− recipients (P = .008, paired t test), indicating increased MHCI−/− target clearance.

Enhanced clearance of MHCI-deficient target cells by ItpkB−/− NK cells. (A) MHCI+/+ or MHCI−/− splenocytes were labeled with low or high CFSE amounts, respectively. A 1:1 mixture was injected IV into WT versus ItpkB−/− mice. CFSElow versus CFSEhigh target cell content in recipient spleens was assessed 24 hours later. (B) Statistical analysis of the ratio (± SEM) of WT control to MHCI−/− targets harvested from recipient spleens (n = 5) revealed significantly underrepresented MHCI−/− targets in ItpkB−/− recipients (P = .008, paired t test), indicating increased MHCI−/− target clearance.

Close Modal

or Create an Account

Close Modal
Close Modal